Liver metastases from carcinoid tumors are usu-ally diffuse at the time of diagnosis, and surgical resection is rarely feasible. The development and clinical application of an analog of soma-tostatin has provided a novel and frequently highly effective tool for control of carcinoid tu-mors; most patients however, become resistant to this therapy. Arterial hypervascularization of most liver metastases from carcinoid tumor ar-gues in favor of hepatic arterial chemoemboliza-tion. We report here a patient with carcinoid tu-mor with liver metastasis who has substantial tumor regression with hepatic artery chemoem-bolization

"/> Liver metastases from carcinoid tumors are usu-ally diffuse at the time of diagnosis, and surgical resection is rarely feasible. The development and clinical application of an analog of soma-tostatin has provided a novel and frequently highly effective tool for control of carcinoid tu-mors; most patients however, become resistant to this therapy. Arterial hypervascularization of most liver metastases from carcinoid tumor ar-gues in favor of hepatic arterial chemoemboliza-tion. We report here a patient with carcinoid tu-mor with liver metastasis who has substantial tumor regression with hepatic artery chemoem-bolization

"/>

Hepatic Artery Chemoembolization for Management of Patient with Advanced Metastatic Carcinoid Tumor: A Case Report

AUTHORS

KS Aljabri 1 , * , H Raef 2

1 Department of Internal Medicine, Prince Mansour Hospital, [email protected], Kingdom of Saudi Arabia

2 Division of Endocrinology,Department of Medicine, King Faisal Specialist Hospital and Research Centre, Kingdom of Saudi Arabia

How to Cite: Aljabri K, Raef H. Hepatic Artery Chemoembolization for Management of Patient with Advanced Metastatic Carcinoid Tumor: A Case Report, Int J Endocrinol Metab. Online ahead of Print ; 5(2):105-108.

ARTICLE INFORMATION

International Journal of Endocrinology and Metabolism: 5 (2); 105-108
Article Type: Case Report
Received: January 21, 2006
Accepted: April 20, 2006
READ FULL TEXT

Abstract

Liver metastases from carcinoid tumors are usu-ally diffuse at the time of diagnosis, and surgical resection is rarely feasible. The development and clinical application of an analog of soma-tostatin has provided a novel and frequently highly effective tool for control of carcinoid tu-mors; most patients however, become resistant to this therapy. Arterial hypervascularization of most liver metastases from carcinoid tumor ar-gues in favor of hepatic arterial chemoemboliza-tion. We report here a patient with carcinoid tu-mor with liver metastasis who has substantial tumor regression with hepatic artery chemoem-bolization

Full Text

Full text is available in PDF

© 0, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
COMMENTS

LEAVE A COMMENT HERE: